Optimal duration of adjuvant targeted-immunotherapy in patients with initially unresectable hepatocellular carcinoma with portal vein tumor thrombus following successful conversion therapy
对于初始无法切除且伴有门静脉癌栓的肝细胞癌患者,在成功进行转化治疗后,辅助靶向免疫治疗的最佳持续时间
期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyag054
Wang, Lei; Feng, Jin-Kai; Zhou, Bin; Liu, Zong-Han; Gong, Lin; Yan, Mao-Lin; Zhao, Hai-Tao; Jiang, Ya-Bo; Shi, Jie; Guo, Wei-Xing; Yuan, Yin; Lu, Chong-De; Cheng, Shu-Qun